Toll Free: 1-888-928-9744
Published: Mar, 2014 | Pages:
66 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Advaxis, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Advaxis, Inc. - Product Pipeline Review - 2014', provides an overview of the Advaxis, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advaxis, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Advaxis, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Advaxis, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Advaxis, Inc.'s pipeline products Reasons to buy - Evaluate Advaxis, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Advaxis, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Advaxis, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Advaxis, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advaxis, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Advaxis, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Advaxis, Inc. Snapshot 6 Advaxis, Inc. Overview 6 Key Information 6 Key Facts 6 Advaxis, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Advaxis, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Advaxis, Inc. - Pipeline Products Glance 12 Advaxis, Inc. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Advaxis, Inc. - Clinical Stage Pipeline Products 13 Phase I Products/Combination Treatment Modalities 13 Advaxis, Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Advaxis, Inc. - Drug Profiles 16 ADXS-HPV 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 ADXS-HER2 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Adxs-LmddA159 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ADXS-PSA 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Bivalent Therapy for Cancer 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Drug Targeting PSCA for Prostate Cancer 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Lm-LLO-CA9 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Lm-LLO-CD-105 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Lm-LLO-CEA 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Lm-LLO-FAP 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Lm-LLO-Flk-1 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Lm-LLO-HER2-CA9 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Lm-LLO-HMW-MAA-C 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 Lm-LLO-IL-13R Alpha2 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 Lm-LLO-ISG-15 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 Lm-LLO-PSA-HMWMAA 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 Lm-LLO-WT-1 48 Product Description 48 Mechanism of Action 48 R&D Progress 48 Lovaxin S 50 Product Description 50 Mechanism of Action 50 R&D Progress 50 Advaxis, Inc. - Pipeline Analysis 51 Advaxis, Inc. - Pipeline Products by Target 51 Advaxis, Inc. - Pipeline Products by Route of Administration 53 Advaxis, Inc. - Pipeline Products by Molecule Type 54 Advaxis, Inc. - Recent Pipeline Updates 55 Advaxis, Inc. - Dormant Projects 63 Advaxis, Inc. - Locations And Subsidiaries 64 Head Office 64 Appendix 65 Methodology 65 Coverage 65 Secondary Research 65 Primary Research 65 Expert Panel Validation 65 Contact Us 66 Disclaimer 66
List of Tables Advaxis, Inc., Key Information 6 Advaxis, Inc., Key Facts 6 Advaxis, Inc. - Pipeline by Indication, 2014 8 Advaxis, Inc. - Pipeline by Stage of Development, 2014 10 Advaxis, Inc. - Monotherapy Products in Pipeline, 2014 11 Advaxis, Inc. - Phase III, 2014 12 Advaxis, Inc. - Phase I, 2014 13 Advaxis, Inc. - Preclinical, 2014 14 Advaxis, Inc. - Pipeline by Target, 2014 52 Advaxis, Inc. - Pipeline by Route of Administration, 2014 53 Advaxis, Inc. - Pipeline by Molecule Type, 2014 54 Advaxis, Inc. - Recent Pipeline Updates, 2014 55 Advaxis, Inc. - Dormant Developmental Projects,2014 63
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.